In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Biomet Deal Opens Door for PE Buyers

Executive Summary

A $10.9 billion bid by a consortium of private equity investors to buy Biomet raises questions about whether this is the first of many such deals or an outlier.

Related Content

Water Street: Finding a Middle-Market PE Niche
Trends for the New Year: Can Medtech Build on the Success of 2007?
Globus Prepared for Trek with $110m from Clarus-led Group
Biomet's Rebirth?
Business & Technology Briefs (06/2007)
Business & Technology Briefs (02/2007)
Dynamic Stabilization Rocks Spine
Industry Perspective - The Medtech Industry: A Look Back at 2006
Encore Medical Goes Private
Biomet Goes Solo in Europe


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts